Diag Capital Management’s Medtronic MDT Stock Holding History

Diag Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$3.29M	Buy	+36,180	New	+$3.38M	3.76%	9

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diag Capital Management's MDT Position: Q4 2018 in Review

Diag Capital Management opened a new position in Medtronic (MDT) in Q4 2018: 36,180 shares worth $3.29M. The stake represents 3.76% of the portfolio and ranks #9 among its holdings.

1,564 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

Diag Capital Management held 36,180 shares of Medtronic worth $3.29M as of Q4 2018.
Medtronic was a new Diag Capital Management position in Q4 2018.
Medtronic made up 3.76% of Diag Capital Management's portfolio in Q4 2018, its #9 holding.
1,564 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.